Related Experiment Video

Updated: Jun 25, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.1K

AI Use in Prostate Cancer: Potential Improvements in Treatments and Patient Care

James B Yu Md Mhs Fastro, Julian C Hong

    Oncology (Williston Park, N.Y.)
    |May 22, 2024
    PubMed

    Abstract:

    Artificial intelligence use in prostate cancer encompasses 4 main areas including diagnostic imaging, prediction of outcomes, histopathology, and treatment planning.

    More Related Videos

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
    08:34

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

    Published on: February 6, 2019

    20.3K
    Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
    09:11

    Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

    Published on: April 9, 2019

    21.5K

    Related Experiment Videos

    Last Updated: Jun 25, 2025

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
    07:25

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

    Published on: March 6, 2018

    13.1K
    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
    08:34

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

    Published on: February 6, 2019

    20.3K
    Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
    09:11

    Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

    Published on: April 9, 2019

    21.5K

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    7.6K
    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    7.6K
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    4.9K
    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    4.9K

    Articles linked to this work by shared authors, journal, and citation graph.

    Evaluation of an Artificial Intelligence Communication Platform for Racial Biases in Pretest Education About Prostate Cancer Germline Testing.

    JCO clinical cancer informatics·2026

    From Zero-Shot to Bedside: A Practical Playbook for Adapting Open-Source Large Language Models to Clinical Symptom Extraction.

    Proceedings of machine learning research·2026

    Impact of Radionecrosis and Local Recurrence on Overall Survival After Stereotactic Radiosurgery for Brain Metastases.

    Advances in radiation oncology·2026

    A single-cell and spatial atlas of prostate cancer reveals the combinatorial nature of gene modules underlying lineage plasticity and metastasis.

    bioRxiv : the preprint server for biology·2026

    Computational identification of salient cancer care topics and themes in oncology social work notes.

    JNCI cancer spectrum·2026

    Association of mental health disorders and all-cause mortality for patients with cancer: Large-scale analysis of University of California Health System Data.

    Cancer·2026

    Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer.

    Oncology (Williston Park, N.Y.)·2026

    Homologous Recombination and Mismatch Repair Assessment in Men With Advanced Prostate Cancer: A Cross-Sectional Study From a Center in Mexico City.

    Oncology (Williston Park, N.Y.)·2026

    Access to Care and Drug Prices: Recent Department of Health and Human Services Guidance.

    Oncology (Williston Park, N.Y.)·2026

    Clinical Outcomes of Acute Pancreatitis in Patients With Multiple Myeloma.

    Oncology (Williston Park, N.Y.)·2026

    Primary Malignant Melanoma of the Colon: A Rare and Challenging Diagnosis.

    Oncology (Williston Park, N.Y.)·2026

    Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.

    Oncology (Williston Park, N.Y.)·2026

    Too much, too little, or just right? The inverted-U relationship between human-AI collaboration modes and eudaimonic well-being.

    Frontiers in psychology·2026

    Algorithmic Targeting in the Iranian-Israeli Confrontation: Technical Realities, Legal thresholds, and the Boundaries of Human Control.

    F1000Research·2026

    Artificial Intelligence Decision-Making in Multidisciplinary Tumor Boards for Head and Neck Cancer: A Systematic Review.

    Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale·2026

    Beyond binary dentistry: Should artificial intelligence think more like clinicians?

    European journal of oral sciences·2026

    From stochastic systems to governed intelligence: a neurosymbolic path for pharma.

    Expert opinion on drug discovery·2026

    Population pharmacokinetic modeling of idarubicin and idarubicinol in Acute Myeloid Leukemia induction therapy: An Ancillary Study of the BIG-1 Trial.

    European journal of pharmacology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us